The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Brexit tussle bogs down UK midcaps

Wed, 23rd Oct 2019 09:15

* FTSE 250 down 0.4%, FTSE 100 up 0.2%

* Fresnillo at bottom of main index after weak outlook

* Exporters benefit from weaker pound
(Adds company news items, updates share moves)

By Muvija M and Shashwat Awasthi

Oct 23 (Reuters) - Shares in domestically-focussed UK
companies slid on Wednesday while those on the blue-chip FTSE
100 inched higher as votes in parliament kept investors guessing
on the final timing and shape of Britain's withdrawal from the
European Union.

With worries over turbulence in Hong Kong and global growth
feeding losses for stock markets globally, the FTSE 250 index of
midcap firms dipped 0.4% by 0745 GMT.

Helped by a dip for the pound in response to Prime
Minister Boris Johnson's failure to get MPs to back his
accelerated Brexit timetable overnight, the exporter-heavy FTSE
100 edged 0.2% higher.

Precious metals miner Fresnillo dropped nearly 2%
after it forecast annual silver and gold production at the lower
end of an already reduced target range, and reported a fall in
quarterly output.

While lawmakers voted for a second hearing on the departure
agreement, rejection of Johnson's timetable raises the
likelihood of another delay in Britain's withdrawal as well as
the prospect of a snap election before Christmas.

"The latest twist in the Brexit saga also means that
investors may have to contend with more political risk by way of
a UK election," said Han Tan, Market Analyst at FXTM.

Raymond James analyst Chris Bailey called the Brexit
situation "a mess" overall and said the core scenario of an
extension or an election was becoming more likely.

The uncertainty around Brexit and its consequences continues
to show up in the performance of UK firms. Housebuilders
, considered among the most vulnerable, lost nearly
1%, with Barratt, Persimmon and Berkeley
the biggest losers on the blue chip index.

That was offset by gains for companies who earn largely in
foreign currencies including British American Tobacco
and pharmaceutical giant GlaxoSmithKline.

Miner Centamin also shone on the FTSE 250 with a 3%
gain after third-quarter production report.
(Reporting by Muvija M and Shashwat Awasthi in Bengaluru;
Editing by Shounak Dasgupta and Patrick Graham)

More News
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.